Cited by 1,361Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery

The DOI matches its Crossref record; 269 of the 275 references it cites were found in a registry or an index.

The evolution of commercial drug delivery technologies

Vargason, Ava M., Anselmo, Aaron C., Mitragotri, Samir·2021·Nature Biomedical Engineering

Open this paper in CoChat — free account

Abstract

Drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation and facilitating patient compliance. As therapeutic modalities expanded beyond small molecules to include nucleic acids, peptides, proteins and antibodies, drug delivery technologies were adapted to address the challenges that emerged. In this Review Article, we discuss seminal approaches that led to the development of successful therapeutic products involving small molecules and macromolecules, identify three drug delivery paradigms that form the basis of contemporary drug delivery and discuss how they have aided the initial clinical successes of each class of therapeutic. We also outline how the paradigms will contribute to the delivery of live-cell therapies.

Integrity signals

Registry

Crossref · 10.1038/s41551-021-00698-w

Cites

269 of 269 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552

Show all 275 references

Research works printed but not linked: 2

Dost, F. H. Der Blutspiegel: Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit (Georg Thieme, 1953).
DeLoach, J. R. & Sprandel, U. (eds) in Bibliotheca Haematologica Vol. 51 (Karger, 1985).

Sorted by citations

Items 601–700 of 1,000

Injectable Senolytic Hydrogel Depot for the Clearance of Senescent Cells
Paganella, L. G., Bovone, G., Cuni, F., Labouesse, C., Cui, Y., Giampietro, C., & Tibbitt, M. W. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.4c00851 · Cited by 12
Nanotechnology-based Approaches for Targeted Drug Delivery to the Small Intestine: Advancements and Challenges
Chandra, P., Ruhela, M., Kumar, P., Porwal, M., Verma, A. K., Sharma, H., & Sachan, N. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128347722250109042022 · Cited by 15
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Tang, L., Peng, S., Zhuang, X., He, Y., Song, Y., Nie, H., Zheng, C., Pan, Z., Lam, A. K.-Y., He, M., et al. (2025) · MedComm – Oncology · doi:10.1002/mog2.70012 · Cited by 11
Advancing drug delivery systems through biomedical engineering: Innovations and future directions
Afrose, N., Chakraborty, R., Bhowmick, P., & Bhowmick, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30146-9.00001-0 · Cited by 10
Recent update on the chemical modalities of mucoadhesive biopolymeric systems for safe and effective drug delivery
Puri, V., Sharma, A., Dheer, D., & Kesharwani, P. (2025) · Applied Materials Today · doi:10.1016/j.apmt.2025.102690 · Cited by 11
DNA Nanotubule‐Based Nanodevices with ATP‐Responsive Gating for Direct Cytosolic Delivery of Nucleic Acids and Proteins
Gao, D., Xu, Z., Li, X., Zhao, Y., Min, Q., Chen, Z., Xu, Q., Tian, Y., Xu, J., & Zhu, J. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505290 · Cited by 11
A Metabolite Co-Delivery Strategy to Improve mRNA Lipid Nanoparticle Delivery
Ma, Y., Fung, V., VanKeulen‐Miller, R., Tiwade, P. B., Narasipura, E. A., Gill, N. A., & Fenton, O. S. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c22969 · Cited by 11
Fluorinated Hexosome Carriers for Enhanced Solubility of Drugs
Guitton-Spassky, T., Schade, B., Zoister, C., Veronese, E., Rosati, M., Bombelli, F. B., Cavallo, G., Thünemann, A. F., Ghermezcheshme, H., Makki, H., et al. (2025) · JACS Au · doi:10.1021/jacsau.5c00198 · Cited by 10
Innovations in additive manufacturing approaches for the fabrication of advanced drug delivery platforms, biomimetics, and predictive 3D microphysiological interfaces
Ghosh, A., Sanyal, A., Kumari, M., Mukerjee, S., Kaity, S., & Roy, S. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01170a · Cited by 10
Optimization of the Mechanical Response in MEX Additive Manufacturing of Thermoplastic Polyimide (PI): The Impact of Key Process Control Settings
Petousis, M., Mountakis, N., Zavos, A., Ntintakis, I., Moutsopoulou, A. J., Spyridaki, M., Nasikas, N. K., Maravelakis, E., & Vidakis, N. (2025) · ACS Omega · doi:10.1021/acsomega.5c08277 · Cited by 10
Latest development and versatile applications of highly integrating drug delivery patch
Chen, Y., An, Q., Teng, K., Zhang, Y., & Zhao, Y. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111164 · Cited by 10
Development of a Novel Pomegranate Polysaccharide Nanoemulsion Formulation with Anti-Inflammatory, Antioxidant, and Antitumor Properties
Sadek, S. A., Hoseny, S. S., Soliman, A. M., & Fahmy, S. R. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220509161548 · Cited by 10
Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells
Li, X., qizi, C. O. T., Khamis, A. M., Zhang, C., & Su, Z. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03284-0 · Cited by 10
Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies
Gabel, M., Knauss, A., Fischer, D., Neurath, M. F., & Weigmann, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213929 · Cited by 13
Virus Management Using Metal–Organic Framework-Based Technologies
Boivin, L., & Harvey, P. D. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c00922 · Cited by 11
Decellularized Tissue-Induced Cellular Recruitment for Tissue Engineering and Regenerative Medicine
Golebiowska, A. A., Jala, V. R., & Nukavarapu, S. P. (2023) · Annals of Biomedical Engineering · doi:10.1007/s10439-023-03182-5 · Cited by 10
“26,51,52 GFs, in particular, including the use of platelet-rich plasma, are largely used for the mobilization and differentiation of MSCs to drive tissue repair.”
Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy
Danielewicz, N., Rosato, F., Tomisch, J., Gräber, J., Wiltschi, B., Striedner, G., Römer, W., & Mairhofer, J. (2023) · ACS Omega · doi:10.1021/acsomega.3c00667 · Cited by 10
Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
Tsai, K., Chang, Y., Huang, C., Prince, G. M. S. H., Chen, H., Makondi, P. T., Shen, Y.-R., & Wei, P. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04363-5 · Cited by 10
Sustained release of a highly specific GSK3β inhibitor SB216763 in the PCL scaffold creates an osteogenic niche for osteogenesis, anti-adipogenesis, and potential angiogenesis
Gong, W., Li, M., Zhao, L., Wang, P., Wang, X., Wang, B., Liu, X., & Tu, X. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1215233 · Cited by 9
“However, smallmolecule drugs have been a research hotspot due to their good stability, solubility, easier processing, and low cost (Vargason et al., 2021).”
Background
Reviewing particulate delivery systems loaded with repurposed tetracyclines – From micro to nanoparticles
Martín, V., Bettencourt, A., Santos, C. F., & Gomes, P. S. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123642 · Cited by 10
Co-delivery of indomethacin and uricase as a new strategy for inflammatory diseases associated with high uric acid
Liu, J., Lin, C., Wu, M., Wang, Y., Chen, S., Yang, T., Xie, C.-L., Kong, Y., Wu, W., Wang, J., et al. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01487-5 · Cited by 10
“Despite its remarkable efficacy, increasing solubility, enhancing stability, bypassing biological barriers, and reducing the immunogenicity of uricase are four main challenges to be overcome [25–27].”
Direct Cytosolic Delivery of Citraconylated Proteins
Goswami, R., Lehot, V., Çiçek, Y. A., Nagaraj, H., Jeon, T., Nguyen, T., Fedeli, S., & Rotello, V. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010218 · Cited by 11
Transformative Materials for Interfacial Drug Delivery
Desai, P. B., Dasgupta, A., Sofias, A. M., Peña, Q., Göstl, R., Slabu, I., Schwaneberg, U., Stiehl, T., Wagner, W., Jockenhoevel, S., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301062 · Cited by 10
Antibody and Cellular-Based Therapies for Pediatric Acute Lymphoblastic Leukemia: Mechanisms and Prospects
Li, W., Zhang, Y., Kankala, R. K., Zou, L., & Chen, Z. (2022) · Pharmacology · doi:10.1159/000524040 · Cited by 9
Industrialization’s eye view on theranostic nanomedicine
Sivasubramanian, M., Lin, L.-J., Wang, Y.-C., Yang, C., & Lo, L. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.918715 · Cited by 9
“, nanoformulation) and restrict their sporadic distribution, thus minimizing off-target toxicity (Rosenblum et al., 2018;Mitchell et al., 2021; Shah et al., 2021; Vargason et al., 2021).”
Background
Particulates are everywhere, but are they harmful in cell and gene therapies?
Molina, S. A., Davies, S. J., Sethi, D., Oh, S., Durand, N., Scott, M., Davies, L. C., Wormuth, K. R., & Clarke, D. M. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.07.014 · Cited by 9
A bioactive microparticle-loaded osteogenically enhanced bioprinted scaffold that permits sustained release of BMP-2
Seok, J. M., Kim, M. J., Park, J. H., Kim, D., Lee, D., Yeo, S. J., Lee, J. H., Lee, K., Byun, J., Oh, S. H., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100685 · Cited by 9
pH ‐dependent swellable hyaluronate nanogels targeting acidic tumors
Song, J., Lee, E., & Lee, E. S. (2023) · Polymers for Advanced Technologies · doi:10.1002/pat.6160 · Cited by 9
The Case for Neurosurgical Intervention in Cancer Neuroscience
Bernstock, J. D., Gerstl, J. V. E., Chen, J., Johnston, B. R., Nonnenbroich, L. F., Spanehl, L., Gessler, F. A., Valdes, P. A., Lu, Y., Srinivasan, S. S., et al. (2024) · Neurosurgery · doi:10.1227/neu.0000000000003039 · Cited by 9
“73 Finally, immunotherapies have commonly failed due to an immune-cold TME.”
Improving the stability of insulin through effective chemical modifications: A Comprehensive review
Kamelnia, R., Ahmadi‐hamedani, M., Darroudi, M., & Kamelnia, E. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124399 · Cited by 9
Gold(III)-Induced Amide Bond Cleavage In Vivo: A Dual Release Strategy via π-Acid Mediated Allyl Substitution
Unnikrishnan, V. B., Sabatino, V., Amorim, F., Estrada, M. F., Navo, C. D., Jiménez‐Osés, G., Fior, R., & Bernardes, G. J. L. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c05582 · Cited by 9
Multi-site enhancement of osteogenesis: peptide-functionalized GelMA hydrogels with three-dimensional cultures of human dental pulp stem cells
Liang, L., Wang, S., Zhang, X., Yan, T., Pan, X., Gao, Y., Zhang, X., Wang, Q., & Liu, Q. (2024) · Regenerative Biomaterials · doi:10.1093/rb/rbae090 · Cited by 9
“However, owing to the rapid clearance of the locally defective region of BFP1 and its limited bioavailability, free administration of BFP1 does not usually achieve the desired therapeutic effect and cannot regulate the entire bone-repair cycle [14, 15].”
Background
Materials approaches for next-generation encapsulated cell therapies
Krishnan, S. R., Langer, R., & Anderson, D. G. (2024) · MRS Communications · doi:10.1557/s43579-024-00678-6 · Cited by 14
Gallic Acid-Encapsulated PAMAM Dendrimers as an Antioxidant Delivery System for Controlled Release and Reduced Cytotoxicity against ARPE-19 Cells
Sripunya, A., Chittasupho, C., Mangmool, S., Angerhofer, A., & Imaram, W. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00475 · Cited by 14
A platform method for simultaneous quantification of lipid and nucleic acid components in lipid nanoparticles
Su, W.-C., Lieu, R., Fu, Y., Kempen, T. J., Yu, Z., Zhang, K., Chen, T., & Fan, Y. (2025) · Journal of Chromatography A · doi:10.1016/j.chroma.2025.465788 · Cited by 11
Diverse Therapeutic Potentials of Hypericin: An In-Depth Review
Maurya, S. K., Divakar, S., Rathee, S., & Patil, U. K. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266330142250224101958 · Cited by 9
Molecular Release by the Rotaxane and Pseudorotaxane Approach
Peñaranda-Navarro, R., Collados-Salmeron, M., Carrilero-Flores, E., & Saura-Sanmartín, A. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202500350 · Cited by 9
Swelling Behavior, Biocompatibility, and Controlled Delivery of Sodium–Diclofenac in New Temperature-Responsive P(OEGMA/OPGMA) Copolymeric Hydrogels
Miladinović, Z. R., Krstic, M., & Suljovrujić, E. H. (2025) · Gels · doi:10.3390/gels11030201 · Cited by 10
“For every drug, delivery aims to optimize therapeutic use by efficiently transporting and releasing the drug to the intended site within the body while simultaneously minimizing accumulation away from the targeted [38].”
Citrullination of NF‐κB p65 by PAD2 as a Novel Therapeutic Target for Modulating Macrophage Polarization in Acute Lung Injury
Yu, X., Song, Y., Dong, T., Ouyang, W., Quan, C., Shao, L.-J.-Z., Barasa, L., Thompson, P. R., Zhang, M., Ma, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202413253 · Cited by 9
Redox-Responsive Cross-Linking of Polycarbonate Nanomedicines for Enhanced Stability and Controlled Drug Delivery
Zhang, X., Zhao, B., Fu, S., Liu, Y., Petrisor, A. A., Yang, Z., Fanos, H. E., Seruya, R. S., & Zhang, F. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c22002 · Cited by 9
Recent Advances in Di-, Tri-Substituted Mono-Thiazoles, and Bis-Thiazoles: Factors Affecting Biological Activities, Future Aspects, and Challenges
Minakshi, M., Kaswan, P., Singh, K., Devi, Singh, R., Yadav, N. K., & Yadav, M. K. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266334873250316102556 · Cited by 9
Multicomponent reaction-based combinatorial chemistry for accelerating the discovery of therapeutic protein and nucleic acid delivery materials
He, Z., Le, Z., Liu, Z., & Chen, Y. (2025) · NPG Asia Materials · doi:10.1038/s41427-025-00595-7 · Cited by 10
Gum Rosin in Medical and Pharmaceutical Applications: From Conventional Uses to Modern Advancements
Siboro, S. A. P., Salma, S. A., Syuhada, Putri, K. S. S., Yuliati, F., Lee, W., & Lim, K. T. (2025) · Materials · doi:10.3390/ma18102266 · Cited by 9
“Each of these materials has specific characteristics, thus exhibit different challenges in formulating them into suitable drug delivery system [57,58].”
MicroRNA-155 in neurodegeneration
Liu, Q., & Siadat, S. D. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120506 · Cited by 9
Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies
Xu, Y., Drucker, D. J., Traverso, G., & Beloqui, A. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf027 · Cited by 9
Insights into microalgal biotechnology: Current applications, key challenges, and future prospects
Zhang, H., Wu, Y., Liu, D., Feng, S., Xuan, X., Dong, G., Cheng, J., Qin, Y., & Ngo, H. H. (2025) · Journal of Environmental Management · doi:10.1016/j.jenvman.2025.127263 · Cited by 10
A review of Lycium barbarum polysaccharides: Structural characteristics, antitumor molecular mechanism and transformation application
Chen, Y., Li, L., Zhang, R., & Liu, F. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148743 · Cited by 10
Polymer Blend Controls Nanoparticles’ Surface Charge for Improved Mucus Penetration and Epithelial Cell Adhesion
Stevens, C. A., Ševarika, B., Wilson, B. K., Wang, C.-M., Cárcamo‐Oyarce, G., Romeo, J., Degen, G. D., Kassis, T., Lehr, C., Carrier, R. L., et al. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c02487 · Cited by 12
Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles
Barros, A. S., Nunes, R., & Sarmento, B. F. C. C. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114466 · Cited by 10
Cyclodextrin and folate functionalized polymer nanocarriers: Chain length dependent properties
Pillai, A. S., Alexander, A., Varalakshmi, G. S., Manikantan, V., Akash, B. A., & Enoch, I. V. M. V. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111550 · Cited by 10
Dendritic lipopeptide liposomes decorated with dual-targeted proteins
Zhou, S., Li, C., Yuan, Y., Jiang, L., Chen, W., & Jiang, X. (2022) · Biomaterials Science · doi:10.1039/d2bm00952h · Cited by 9
The future of hepatology – “The best way to predict the future is to create it”
Berg, T., & Krag, A. A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.022 · Cited by 9
Engineering of Therapeutic and Detoxifying Enzymes
Michailidou, F. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202308814 · Cited by 9
State-of-the-Art Approaches to Heterologous Expression of Bispecific Antibodies Targeting Solid Tumors
Misorin, A. K., Chernyshova, D. O., & Karbyshev, M. S. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923090031 · Cited by 9
Pemetrexed-layered double hydroxide with Eudragit® S100; 2D van der Waals nanohybrid with drug delivery function
Piao, H., Choi, G., Rejinold, N. S., Yu, J., Choi, S., & Choy, J. (2023) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2023.10.012 · Cited by 9
In vivo gene delivery to immune cells
Siebart, J. C., Chan, C. S., Yao, X., Su, F., & Kwong, G. A. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103169 · Cited by 11
Tetraphenylethylene‐Featured Fluorescent Supramolecular Nanoparticles for Intracellular Trafficking of Protein Delivery and Neuroprotection
Liu, J., Sheng, J., Shao, L., Zheng, Q., Li, W., Chen, X., Mao, L., & Wang, M. (2021) · Angewandte Chemie · doi:10.1002/ange.202111213 · Cited by 9
Distribution- and Metabolism-Based Drug Discovery: A Potassium-Competitive Acid Blocker as a Proof of Concept
Wang, M., Gong, Y., Zhuo, L., Shi, X.-X., Tian, Y.-G., Huang, C., Huang, W., & Yang, G. (2022) · Research · doi:10.34133/2022/9852518 · Cited by 9
“In addition, ADCs do not change the metabolic properties of the original drugs; therefore, toxicity-inducing metabolites are still formed, exposing the systemic compartment to their toxic effects [25].”
Influential
Recombinant protein polymers as carriers of chemotherapeutic agents
Phour, A., Gaur, V., Banerjee, A., & Bhattacharyya, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114544 · Cited by 9
Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2
Das, A., Ghosh, M., Gupta, P. K., & Rana, S. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30360 · Cited by 9
“The good thing about small molecule drugs is that they are orally bioavailable with relatively short half‐lives than the antibodies.(34,35) Thus, the desired balance between the physiological and pathological concentration of C5a can”
Background
The Development of a Polysaccharide-Based Hydrogel Encapsulating Tobramycin-Loaded Gelatine Microspheres as an Antibacterial System
Shi, M., Xu, Y., Li, S., Wang, L., Gu, J., & Zhang, Y.-X. (2023) · Gels · doi:10.3390/gels9030219 · Cited by 9
“Although TOB exhibits excellent antibacterial activity, such small molecule drug may diffuse quickly on the surface of the infected wounds and lead to burst release [10].”
Background
Surface modified cationic PLGA microparticles as long-acting injectable carriers for intra-articular small molecule drug delivery
Kotla, N. G., Langlois, J., Fisch, A., Krämer, I., & Halleux, C. M. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.10.020 · Cited by 8
A hollow Ag/AgCl nanoelectrode for single-cell chloride detection
Zhang, T., Liu, F.-Q., Li, Z., Xu, Y., Zhao, W., Chen, H., & Xu, J. (2024) · Chemical Communications · doi:10.1039/d3cc06078k · Cited by 8
Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects
Mazahir, F., Alam, M. I., & Yadav, A. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102318 · Cited by 9
Dynamic Covalent Boronate Chemistry Accelerates the Screening of Polymeric Gene Delivery Vectors via In Situ Complexation of Nucleic Acids
Gonzalez, B. D., Lopez-Blanco, R., Parcero-Bouzas, S., Barreiro-Piñeiro, N., Garcia-Abuin, L., & Fernández-Megía, E. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c03384 · Cited by 8
Targeted Reprogramming of Pathogenic Fibroblast Genes at the 3′-Untranslated Regions by DNA Nanorobots for Periodontitis
Zhang, J., Liu, Y., Zeng, H., Zhao, Z., Han, Y., Zhao, Y., Qu, S., Gong, Z., Wang, Z., Bai, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c05475 · Cited by 9
Fluorinated Peptide Hydrogels Result in Longer In Vivo Residence Time after Subcutaneous Administration
Honfroy, A., Bertouille, J., Turea, A.-M., Cauwenbergh, T., Bridoux, J., Lensen, N., Mangialetto, J., Brande, N. P. V. D., White, J., Gardiner, J., et al. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00872 · Cited by 9
A Magnetically Driven Biodegradable Microsphere with Mass Production Capability for Subunit Vaccine Delivery and Enhanced Immunotherapy
Zhang, Q., Qu, Y., Zhao, H. Q., Chen, S., Li, H., Li, J., Li, Y., Li, J., & Sun, D. B. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c10301 · Cited by 8
pH : A major player in degenerative intervertebral disks
Trone, M. A. R., Stover, J. D., Almarza, A. J., & Bowles, R. D. (2024) · JOR Spine · doi:10.1002/jsp2.70025 · Cited by 8
Design of an anti-PD-L1-mediated MOF nanodrug delivery system using terpyridine-metal coordination for tumor theranostics
Han, X., Chen, J., Cheng, Z., & Zhou, S. (2024) · Chemical Communications · doi:10.1039/d4cc05933f · Cited by 8
Immune-modulating nanomedicines for enhanced drug delivery to non-small-cell lung cancer
Liu, F., Howard, C. B., Huda, P., Fletcher, N. L., Bell, C. A., Blakey, I., Agrez, M., & Thurecht, K. J. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123089 · Cited by 8
Wearable transdermal drug delivery system controlled by wirelessly powered acoustic waves
Zhang, J., Yang, F., Wu, H., Ong, H., Arnold, P., Zhang, M., Jiang, Y., Bahar, D., Yuan, Z., Yang, X., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113619 · Cited by 8
“For example, commonly only those hydrophobic drug molecules less than 500 Da can be effectively and passively diffused through the stratum corneum (SC), the outermost layer of the epidermis [10,11].”
Stimulus switches for spatial-temporal precision in therapeutic delivery systems
Zhang, F., Li, J., Gao, Y., Wei, Y., Wen, D., & Wang, Z. (2024) · Nano Research · doi:10.26599/nr.2025.94907571 · Cited by 9
Dual‐Function Plant‐Derived Nanovesicles From Regenerated Cannabis sativa Roots for Immunotherapy and Vaccine Delivery
Park, S. H., Choi, H., Li, Z., Kim, Y. H., Lee, H. J., Shin, K., Kim, H., Kwon, H., Seo, G., Jeong, J. C., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70206 · Cited by 9
“Most DDSs are designed to serve as carriers that enhance the stability and efficacy of drugs or vaccines, including DNA, RNA and proteins (Vargason et al. 2021; Adepu and Ramakrishna 2021; Ezike et al. 2023).”
Eutectogels as versatile platforms: design strategies and application prospects
Zhang, J., Hao, S., Yang, J. H., Zhang, J., Wen, J., Ren, W., Wang, B., Xiao, L., Shao, C., & Sun, R. (2026) · Green Chemistry · doi:10.1039/d5gc05556c · Cited by 8
Programmable next-generation supramolecular self-assembled materials as drug delivery systems
Fu, H., Gao, W., Tang, Y., Liu, X., Wang, M., Zhang, J., Liu, T., & Zhang, J. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.01.040 · Cited by 14
“The main challenges include: (i) ensuring drug molecule activity and stability; (ii) enhancing targeted distribution to diseased tissues and cells; (iii) promoting drug transport across biological barriers; (iv) optimizing intracellular drug transport and release [14 – 18].”
Strategies to improve intracellular delivery of arginine-rich cell-penetrating peptides
ANJOUS, R., Kavyashree, P., & Saha, A. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02935j · Cited by 8
Overcoming barriers to delivery of biologics by novel approaches and advanced delivery systems
Ahator, S. D., Franzè, S., Obuobi, S. A. O., Anderluzzi, G., Flaten, G. E., & Škalko‐Basnet, N. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115875 · Cited by 10
Quercetin Loaded Rifampicin-Floating Microspheres for Improved Stability and In-vitro Drug Release
Pingale, P. L., & Amrutkar, S. V. (2021) · Pharmacophore · doi:10.51847/ybxnl2bsuh · Cited by 8
Targeted Nanocarriers for Systemic Delivery of IRAK4 Inhibitors to Inflamed Tissues
Park, Y., Korzun, T., Moses, A. S., Singh, P., Levasseur, P. R., Demessie, A. A., Sharma, K. S., Morgan, T. K., Raitmayr, C. J., Avila, U., et al. (2023) · Small · doi:10.1002/smll.202306270 · Cited by 9
Encapsulins: Nanotechnology’s future in a shell
Quinton, A. R., McDowell, H. B., & Hoiczyk, E. (2023) · Advances in applied microbiology · doi:10.1016/bs.aambs.2023.09.001 · Cited by 8
Bacterial Flagellum–Drug Nanoconjugates for Carrier‐Free Immunochemotherapy
Fu, Z., Wang, L., Guo, H., Lin, S., Huang, W., & Pang, Y. (2023) · Small · doi:10.1002/smll.202306303 · Cited by 8
Self-assembled Janus base nanotubes: chemistry and applications
Zhang, W., & Chen, Y. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1346014 · Cited by 8
“These include targeted drug delivery systems (Chen et al., 2011; Yau et al., 2021a; Vargason et al., 2021), cutting-edge imaging agents for disease diagnostics (Chapman et al., 2013; Han et al., 2019), inventive tissue engineering scaffolds (Zhou et al., 2020; Zhou et al., 2021a; Yau et al., 2021b;…”
Background
Self‐Supplied Reactive Oxygen Species‐Responsive Mitoxantrone Polyprodrug for Chemosensitization‐Enhanced Chemotherapy under Moderate Hyperthermia
Zhang, H., Wang, J., Wu, R., Zheng, B., Sang, Y., Wang, B., Song, L., Hu, Y. Z., & Ma, X. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303631 · Cited by 8
Novel CAR-T cells targeting TRKB for the treatment of solid cancer
Liang, D., Tang, J., Sun, B., He, S., Yang, D., Ma, H., Yun, Y., Zhu, Y., Wei, W., Chen, H., et al. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01936-7 · Cited by 8
“Recently, chimeric antigen receptor (CAR) T cells have been prominent as a live-cell therapy approach that is developing rapidly and achieving promising results [1].”
Analytical Modeling of Flowrate and Its Maxima in Electrochemical Bioelectronics with Drug Delivery Capabilities
Avila, R. O., Wu, Y., Garziera, R., Rogers, J. A., & Huang, Y. Y. (2022) · Research · doi:10.34133/2022/9805932 · Cited by 8
Sol—gel synthesis, properties and protein loading/delivery capacity of hollow bioactive glass nanospheres with large hollow cavity and mesoporous shell
El‐Fiqi, A. (2022) · Frontiers of Materials Science · doi:10.1007/s11706-022-0608-6 · Cited by 8
“, polydopamine and organosilica [28–30]) were reported for drug/gene delivery and therapeutic applications [4].”
Background
Overcoming PEG─Protein Mutual Repulsion to Improve the Efficiency of PEGylation
Meziadi, A., Zuberi, N., de Haan, H. W., & Gauthier, M. A. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c01192 · Cited by 8
Perspective on the Application of Erythrocyte Liposome-Based Drug Delivery for Infectious Diseases
Krivić, H., Himbert, S., & Rheinstadter, M. C. (2022) · Membranes · doi:10.3390/membranes12121226 · Cited by 8
“The goal of drug delivery technologies is to improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation, and facilitating patient compliance [1].”
Background
Localized Instillation Enables In Vivo Screening of Targeting Peptides Using One-Bead One-Compound Technology
Yan, Y.-Q., Wang, J., Zhang, L., Yang, P., Ye, X.-W., Liu, C., Hou, D., Lai, W., Wang, J., Zeng, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c09894 · Cited by 9
Hydrogen sulfide detection induced burst release of model drug from polymeric micelles
Sharma, R., Suhendra, N. F., & Lee, H. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.133570 · Cited by 8
Injectable Devices for Delivery of Liquid or Solid Protein Formulations
Bernards, D. A., Ma, C. J., Zhang, Y., Rodriguez, T. M., Dickson, J., Kharbikar, B. N., Bhisitkul, R. B., & Desai, T. A. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00004 · Cited by 8
Design of a light-responsive porphyrin/polysaccharide hybrid film for smart release of hydrocortisone
Quadrado, R. F. N., Burgo, T. A. L., Fussinger, T. D., Rossi, G. G., de Campos, M. M. A., Iglesias, B. A., & Fajardo, A. R. (2023) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2023.131877 · Cited by 8
The sedimentation behaviors of elliptical active particles in a rectangular box
Liu, C., Ouyang, Z., & Lin, J. (2023) · Journal of Fluids and Structures · doi:10.1016/j.jfluidstructs.2023.104039 · Cited by 8
Leveraging next-generation materials for cancer neuroscience therapies in the central nervous system
Bernstock, J. D., Johnston, B. R., Friedman, G. K., Chiocca, E. A., Langer, R., & Srinivasan, S. S. (2024) · Nature Reviews Materials · doi:10.1038/s41578-024-00681-2 · Cited by 7
“Material science advancements including polymeric, nanoparticle, microcapsule, ultrasound-or mechanically released systems, injectable and bio-responsive approaches have enabled improved targeting, tunable kinetics, penetration, absorption and spatiotemporal delivery 14 .”
Recent advances in PAMAM mediated nano-vehicles for targeted drug delivery in cancer therapy
Patle, R. Y., & Dongre, R. S. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2428966 · Cited by 7
“…drug delivery systems (MDDS) gained supremacy due to the profuse therapeutic modulation desired for effective diagnosis and treatment [1,2]. traditional cancer therapy comprehends the intravenous chemo-therapeutic measures that suffer from significant drawbacks such as meagre drug…”
Therapeutic co-assemblies for synergistic NSCLC treatment through dual topoisomerase I and tubulin inhibitors
Xiong, H., Du, C., Ye, J., Zhang, H., Qin, Y., Zeng, F., Song, R., Shi, C., Guo, H., Chen, J., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.054 · Cited by 7
Autodegradable Polymers: Complete Degradation without Any Trigger, Tunable Performance, and Biomedical Applications
Chen, S., Zhang, C., & Zhang, X. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c14077 · Cited by 8
Defining Structure‐Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra‐Stable Biopharmaceuticals
Prossnitz, A. N., Nguyen, L. T., Eckman, N., Borkar, S., Tetef, S., Autzen, A. A. A., Fuller, G. G., & Appel, E. A. (2025) · Advanced Science · doi:10.1002/advs.202409604 · Cited by 7
“3 As proteins are inherently amphiphilic, many are highly prone to aggregation induced by hydrophobic interfaces, such as air or silanized glass, significantly limiting shelf-stability and efficacy.”
Chemical catalyst manipulating cancer epigenome and transcription
Yamanashi, Y., Takamaru, S., Okabe, A., Kaito, S., Azumaya, Y., Kamimura, Y. R., Yamatsugu, K., Kujirai, T., Kurumizaka, H., Iwama, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56204-2 · Cited by 7
“In addition, using targeted drug-delivery systems, such as nanoparticles, could improve the ef ﬁ cient delivery of the catalyst into target cancer cells in vivo 43 .”

Authors: Vargason, A. M., Anselmo, A. C., & Mitragotri, S.
Affiliations: University of North Carolina at Chapel Hill (US)
Harvard University (US)
Corresponding author: Mitragotri, Samir
ORCID: Vargason, Ava M.
Anselmo, Aaron C.
Mitragotri, Samir
Venue: Nature Biomedical Engineering
Publisher: Springer Science and Business Media LLC
Published: 2021-04-01
Volume: 5
Issue: 9
Pages: 951-967
ISSN: 2157-846X (ISSN-L)
DOI: 10.1038/s41551-021-00698-w
OpenAlex: W3143156272
Cited by: 1,361
References: 275
Citations by year: 2026: 170 · 2025: 314 · 2024: 366 · 2023: 293 · 2022: 170 · 2021: 48
FWCI: 19.23
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Biomedical Engineering (publishedVersion)
PubMed (publishedVersion)
Funders: National Science Foundation (DGE-1650116)
U.S. Department of Health & Human Services | National Institutes of Health (R35GM137898, 1R01HL143806-01)
United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-15-1-0045)
U.S. Department of Defense (W81XWH-19-2-0011)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: drug delivery technology, small molecules, macromolecules, nucleic acids, proteins, immunoglobulins, medication adherence
MeSH terms: Pharmaceutical Preparations, Humans, Nucleic Acids, Peptides, Proteins, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The evolution of commercial drug delivery technologies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks